SCHEMBL12817846

SCHEMBL12817846

Cc1nc2ccc(S(=O)(=O)N3CCOc4ccc(-c5cnco5)cc43)cc2s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ HTT P42858 1/20 0.43
▸ MEN1 O00255 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ PKM P14618 3/20 0.42
▸ PKLR P30613 1/20 0.42
▸ KDM2B Q8NHM5 1/20 0.41
▸ CYP2C9 P11712 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ TP53 P04637 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818569 0.84 PKM (0.42) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12818343 0.82 LMNA (0.41) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12818620 0.82 LMNA (0.42) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12817618 0.82 MEN1 (0.41) MEN1KMT2ACYP2C9MAPTTP53
SCHEMBL12818373 0.81 SMN1; SMN2 (0.42) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12818708 0.81 BRD4 (0.45) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12819198 0.81 LMNA (0.41) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12818394 0.81 LMNA (0.41) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12818318 0.80 LMNA (0.42) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL12817802 0.80 LMNA (0.42) LMNASMN1; SMN2HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback